Nuno Dinis Alves (Ph.D.) is a Junior Researcher with training and expertise in neural plasticity, neuronal circuitries, and behavioral neuroscience, and specialized in various in vivo methodologies in mouse models of disease. Nuno is interested in dissecting the behavioral contribution of the serotonergic circuits (brain and gut) and unraveling novel therapeutic strategies to rescue behavioral dysfunctions of mental illness. Currently, he combines preclinical and clinical studies to elucidate the therapeutic potential of pharmacologic modulation of selective serotonergic pathways to rescue stress-induced cognitive inflexibility and social impairments. He is also interested in dissecting the improving actions of psychedelic drugs, in particular psilocybin, in the context of stress-related neuropsychiatric drugs. Nuno is graduated in Biochemistry from the University of Trás-os-Montes and Alto Douro (UTAD, 2009) and master in Cell and Molecular Biology from the University of Coimbra (2011), during which he developed his master’s thesis at Janssen Pharmaceutica (Beerse, Belgium). He completed his Ph.D. in Health Sciences at the University of Minho (2017) under the supervision of Dr. Luísa Pinto and Dr. Nuno Sousa. During his doctoral studies, Nuno studied the importance of adult neural plasticity in depression. He revealed that typical antidepressants induce either resilience or susceptibility to recurrent depression according to their neurogenic capacity. He then performed his post-doc at the Columbia University (New York, US) and under the supervision of Dr. Mark Ansorge and Dr. Jay Gingrich, Nuno found that serotonin medial prefrontal is necessary and sufficient to cognitive flexibility. In a collaborative study with Dr. Kara Margolis (New York University), he revealed that modulation of serotonin specifically in the gut intestinal epithelium, interferes with anxiety- and depression-like behaviors.
Nuno Dinis Alves (Ph.D.) is a Junior Researcher with training and expertise in neural plasticity, neuronal circuitries, and behavioral neuroscience, and specialized in various in vivo methodologies in mouse models of disease. Nuno is interested in dissecting the behavioral contribution of the serotonergic circuits (brain and gut) and unraveling novel therapeutic strategies to rescue behavioral dysfunctions of mental illness. Currently, he combines preclinical and clinical studies to elucidate the therapeutic potential of pharmacologic modulation of selective serotonergic pathways to rescue stress-induced cognitive inflexibility and social impairments. He is also interested in dissecting the improving actions of psychedelic drugs, in particular psilocybin, in the context of stress-related neuropsychiatric drugs. Nuno is graduated in Biochemistry from the University of Trás-os-Montes and Alto Douro (UTAD, 2009) and master in Cell and Molecular Biology from the University of Coimbra (2011), during which he developed his master’s thesis at Janssen Pharmaceutica (Beerse, Belgium). He completed his Ph.D. in Health Sciences at the University of Minho (2017) under the supervision of Dr. Luísa Pinto and Dr. Nuno Sousa. During his doctoral studies, Nuno studied the importance of adult neural plasticity in depression. He revealed that typical antidepressants induce either resilience or susceptibility to recurrent depression according to their neurogenic capacity. He then performed his post-doc at the Columbia University (New York, US) and under the supervision of Dr. Mark Ansorge and Dr. Jay Gingrich, Nuno found that serotonin medial prefrontal is necessary and sufficient to cognitive flexibility. In a collaborative study with Dr. Kara Margolis (New York University), he revealed that modulation of serotonin specifically in the gut intestinal epithelium, interferes with anxiety- and depression-like behaviors.
FEATURED PUBLICATIONS:
Complete List of Peer-reviewed publications (23): https://www.ncbi.nlm.nih.gov/myncbi/1lSUBHjYkvpgBD/bibliography/public/
PRIZES and AWARDS:
– Sackler Innovation Award by Columbia University (2022);
– Maria de Sousa Award by Bial Foundation and Portuguese Order of Physicians (2023);
Relevant Activities in Scientific Societies:
– Chapter Representative of the Minho-Portugal Chapter of the Society for Neuroscience (SfN);
– Spokesperson of the Young Mediterranean Neuroscience Society Committee (YMNSC);
– Member of the Early Career Shell of the European College of Neuropsychopharmacology (ECNP) Thematic Network on Resilience.
Depression affects around 16% of the world population and is the leading cause of disability worldwide. This means that around 300 million people are now living with depression…
The adult mammalian brain harbors different forms of neural plasticity, ranging from neuronal synapto-dendritic rearrangements to the generation of new neuronal…
Phone: +351 253 604 967
Fax: +351 253 604 809
Email: icvs.sec@med.uminho.pt
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
Copyright ©2022 ICVS. All Rights Reserved
Copyright ©2022 ICVS. All Rights Reserved
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
Copyright ©2022 ICVS. All Rights Reserved
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
